FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003403665> ?p ?o ?g. }

• W2003403665 endingPage "738" @default.
• W2003403665 startingPage "734" @default.
• W2003403665 abstract "Aim: To determine whether supplemental oral vitamin E is effective in lowering serum aminotransferase and alkaline phosphatase levels in children with nonalcoholic steatohepatitis (NASH) associated with obesity. Study design: Open-label pilot study enrolling all children <16 years old with chronically elevated serum aminotransferase (alanine aminotransferase and aspartate aminotransferase) levels for greater than 3 months, who demonstrated a diffusely echogenic liver on uhvasonography, had no demonstrable reason for abnormal serum chemistry values other than obesity, and therefore were diagnosed to have NASH. Patients were prescribed oral vitamin E between 400 and 1200 IU per day. Serum chemistry values were monitored monthly during treatment. Results: Eleven subjects with a mean age of 12.4 years were enrolled; treated patients were followed up for 4 to 10 months. The body mass index did not change significantly before and after treatment (32.8 ± 3.8 kg/m2 vs 32.5 ± 4.4 kg/m2, respectively). Serum alanine aminotransferase decreased from 175 ± 106 IU/L to 40 ± 26 IU/L (P < .001, paired Student t test), serum aspartate aminotransferase decreased from 104 ± 61 IU/L to 33 ± 11 IU/L (P < .002), and alkaline phosphatase decreased from 279 ± 42 IU/L to 202 ± 66 IU/L (P < .003) during treatment. Serum aminotransferase levels remained normal during treatment but returned to abnormal in those electing to stop treatment. Serum α-tocopherol levels were within the normal range before the commencement of therapy and increased significantly with supplementation. The liver remained diffusely echogenic during therapy, at the time serum aminotransferase levels were reduced. Conclusions: Daily oral vitamin E administration normalized serum aminotransferase and alkaline phosphatase levels in children with NASH. Obese children with NASH should be encouraged to lose weight as part of a comprehensive weight reduction program and to consider taking supplemental α-tocopherol. Aim: To determine whether supplemental oral vitamin E is effective in lowering serum aminotransferase and alkaline phosphatase levels in children with nonalcoholic steatohepatitis (NASH) associated with obesity. Study design: Open-label pilot study enrolling all children <16 years old with chronically elevated serum aminotransferase (alanine aminotransferase and aspartate aminotransferase) levels for greater than 3 months, who demonstrated a diffusely echogenic liver on uhvasonography, had no demonstrable reason for abnormal serum chemistry values other than obesity, and therefore were diagnosed to have NASH. Patients were prescribed oral vitamin E between 400 and 1200 IU per day. Serum chemistry values were monitored monthly during treatment. Results: Eleven subjects with a mean age of 12.4 years were enrolled; treated patients were followed up for 4 to 10 months. The body mass index did not change significantly before and after treatment (32.8 ± 3.8 kg/m2 vs 32.5 ± 4.4 kg/m2, respectively). Serum alanine aminotransferase decreased from 175 ± 106 IU/L to 40 ± 26 IU/L (P < .001, paired Student t test), serum aspartate aminotransferase decreased from 104 ± 61 IU/L to 33 ± 11 IU/L (P < .002), and alkaline phosphatase decreased from 279 ± 42 IU/L to 202 ± 66 IU/L (P < .003) during treatment. Serum aminotransferase levels remained normal during treatment but returned to abnormal in those electing to stop treatment. Serum α-tocopherol levels were within the normal range before the commencement of therapy and increased significantly with supplementation. The liver remained diffusely echogenic during therapy, at the time serum aminotransferase levels were reduced. Conclusions: Daily oral vitamin E administration normalized serum aminotransferase and alkaline phosphatase levels in children with NASH. Obese children with NASH should be encouraged to lose weight as part of a comprehensive weight reduction program and to consider taking supplemental α-tocopherol." @default.
• W2003403665 created "2016-06-24" @default.
• W2003403665 creator A5023720526 @default.
• W2003403665 date "2000-06-01" @default.
• W2003403665 modified "2023-10-16" @default.
• W2003403665 title "Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study" @default.
• W2003403665 cites W1522553235 @default.
• W2003403665 cites W1970570571 @default.
• W2003403665 cites W1972919500 @default.
• W2003403665 cites W1979590516 @default.
• W2003403665 cites W2015977503 @default.
• W2003403665 cites W2034982710 @default.
• W2003403665 cites W2039691448 @default.
• W2003403665 cites W2052691143 @default.
• W2003403665 cites W2076204761 @default.
• W2003403665 cites W2084310268 @default.
• W2003403665 cites W2091214746 @default.
• W2003403665 cites W2123650181 @default.
• W2003403665 cites W2144178804 @default.
• W2003403665 cites W2335531945 @default.
• W2003403665 doi "https://doi.org/10.1016/s0022-3476(00)05040-x" @default.
• W2003403665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10839868" @default.
• W2003403665 hasPublicationYear "2000" @default.
• W2003403665 type Work @default.
• W2003403665 sameAs 2003403665 @default.
• W2003403665 citedByCount "429" @default.
• W2003403665 countsByYear W20034036652012 @default.
• W2003403665 countsByYear W20034036652013 @default.
• W2003403665 countsByYear W20034036652014 @default.
• W2003403665 countsByYear W20034036652015 @default.
• W2003403665 countsByYear W20034036652016 @default.
• W2003403665 countsByYear W20034036652017 @default.
• W2003403665 countsByYear W20034036652018 @default.
• W2003403665 countsByYear W20034036652019 @default.
• W2003403665 countsByYear W20034036652020 @default.
• W2003403665 countsByYear W20034036652021 @default.
• W2003403665 countsByYear W20034036652022 @default.
• W2003403665 countsByYear W20034036652023 @default.
• W2003403665 crossrefType "journal-article" @default.
• W2003403665 hasAuthorship W2003403665A5023720526 @default.
• W2003403665 hasConcept C126322002 @default.
• W2003403665 hasConcept C134018914 @default.
• W2003403665 hasConcept C160160445 @default.
• W2003403665 hasConcept C181199279 @default.
• W2003403665 hasConcept C185592680 @default.
• W2003403665 hasConcept C2780221984 @default.
• W2003403665 hasConcept C2992872382 @default.
• W2003403665 hasConcept C55493867 @default.
• W2003403665 hasConcept C71924100 @default.
• W2003403665 hasConcept C90924648 @default.
• W2003403665 hasConceptScore W2003403665C126322002 @default.
• W2003403665 hasConceptScore W2003403665C134018914 @default.
• W2003403665 hasConceptScore W2003403665C160160445 @default.
• W2003403665 hasConceptScore W2003403665C181199279 @default.
• W2003403665 hasConceptScore W2003403665C185592680 @default.
• W2003403665 hasConceptScore W2003403665C2780221984 @default.
• W2003403665 hasConceptScore W2003403665C2992872382 @default.
• W2003403665 hasConceptScore W2003403665C55493867 @default.
• W2003403665 hasConceptScore W2003403665C71924100 @default.
• W2003403665 hasConceptScore W2003403665C90924648 @default.
• W2003403665 hasIssue "6" @default.
• W2003403665 hasLocation W20034036651 @default.
• W2003403665 hasLocation W20034036652 @default.
• W2003403665 hasOpenAccess W2003403665 @default.
• W2003403665 hasPrimaryLocation W20034036651 @default.
• W2003403665 hasRelatedWork W1976982520 @default.
• W2003403665 hasRelatedWork W1979139803 @default.
• W2003403665 hasRelatedWork W2009708970 @default.
• W2003403665 hasRelatedWork W2035248654 @default.
• W2003403665 hasRelatedWork W2291547504 @default.
• W2003403665 hasRelatedWork W2320124730 @default.
• W2003403665 hasRelatedWork W2327067714 @default.
• W2003403665 hasRelatedWork W2737129620 @default.
• W2003403665 hasRelatedWork W2748952813 @default.
• W2003403665 hasRelatedWork W4287273846 @default.
• W2003403665 hasVolume "136" @default.
• W2003403665 isParatext "false" @default.
• W2003403665 isRetracted "false" @default.
• W2003403665 magId "2003403665" @default.
• W2003403665 workType "article" @default.